News

Researchers from the American Cancer Society say public education on this topic continues to save a total of around 4,000,000 ...
Boehringer Ingelheim reported new and updated data from the Beamion LUNG-1 trial evaluating zongertinib in previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer ...